ConductScience.org, home

Paper53329

Clinical and serological analysis of transfusion-associated hepatitis.

Alter HJ and 5 others. Lancet, 1975. Cited by 319 papers, by iCite.

Cite this record

ConductScience Library. Clinical and serological analysis of transfusion-associated hepatitis. Papers, record 53329. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/53329

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical and serological analysis of transfusion-associated hepatitis.
PubMed
Journal
Lancet
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
319
iCite
Relative citation ratio, by iCite
9.78
iCite
Revised in PubMed
2019-06-10
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alter HJH J
2Holland PVP V
3Morrow AGA G
4Purcell RHR H
5Feinstone SMS M
6Moritsugu YY

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hepatitis BMajor topic
Transfusion ReactionMajor topic
Adult
Alanine Transaminase
Antibodies, Viral
Aspartate Aminotransferases
Bilirubin
Blood Donors
Blood Specimen Collection
Cytomegalovirus
Hemagglutination Tests
Hepatitis B Antigens
Hepatitis B virus
Hepatovirus
Herpesvirus 4, Human
Humans
Prospective Studies
Radioimmunoassay

Source PubMed

Download CSV of topics

Cited by70

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 319 citations.

PMIDTitleJournalYearIn PapersSource
42478159Direct-Acting Antiviral Therapy and Hepatocellular Carcinoma in Captive Chimpanzees With Long-Standing Chronic Hepatitis C Virus Infection.J Med Virol2026https://conductscience.org/library/papers/42478159PubMed
39205233Risk Factors Associated with Hepatitis C Subtypes and the Evolutionary History of Subtype 1a in Mexico.Viruses2024https://conductscience.org/library/papers/39205233PubMed
37632090Discovery of Hepatitis E and Its Impact on Global Health: A Journey of 44 Years about an Incredible Human-Interest Story.Viruses2023https://conductscience.org/library/papers/37632090PubMed
37614826Hepatitis C Virus: Insights Into Its History, Treatment, Challenges, and Future Directions.Cureus2023https://conductscience.org/library/papers/37614826PubMed
36680254Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative Review.Viruses2023https://conductscience.org/library/papers/36680254PubMed
35595834Breakthroughs in hepatitis C research: from discovery to cure.Nat Rev Gastroenterol Hepatol2022https://conductscience.org/library/papers/35595834PubMed
34578419The Inaugural Australian Centre for Hepatitis Virology Public Panel Discussion on Viral Hepatitis Research-Lessons in Scientific Community Outreach.Viruses2021https://conductscience.org/library/papers/34578419PubMed
34517450[Progress in prevention and control of viral hepatitis since the establishing of the People's Republic of China].Zhonghua Gan Zang Bing Za Zhi2021https://conductscience.org/library/papers/34517450PubMed
34245922The 2020 Nobel Prize in medicine for the discovery of hepatitis C virus: An epic saga of the fight against a troublesome virus.Biomed J2021https://conductscience.org/library/papers/34245922PubMed
33976895A mini-review on sofosbuvir and daclatasvir treatment in coronavirus disease 2019.New Microbes New Infect2021https://conductscience.org/library/papers/33976895PubMed
33505148Human hepatitis viruses-associated cutaneous and systemic vasculitis.World J Gastroenterol2021https://conductscience.org/library/papers/33505148PubMed
33430338Liver Abnormalities after Elimination of HCV Infection: Persistent Epigenetic and Immunological Perturbations Post-Cure.Pathogens2021https://conductscience.org/library/papers/33430338PubMed
33337581Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020.Kaohsiung J Med Sci2021https://conductscience.org/library/papers/33337581PubMed
33261650Hepatitis C: milestones from discovery to clinical cure.Mil Med Res2020https://conductscience.org/library/papers/33261650PubMed
32655240The Discovery of Hepatitis Viruses: Agents and Disease.J Clin Exp Hepatol2020https://conductscience.org/library/papers/32655240PubMed
30875640Taming a beast: lessons from the domestication of hepatitis C virus.Curr Opin Virol2019https://conductscience.org/library/papers/30875640PubMed
30593647Mouse Models for Studying HCV Vaccines and Therapeutic Antibodies.Methods Mol Biol2019https://conductscience.org/library/papers/30593647PubMed
28824743Is the 25-year hepatitis C marathon coming to an end to declare victory?World J Hepatol2017https://conductscience.org/library/papers/28824743PubMed
27784846Hepatitis C Virus and Antiviral Drug Resistance.Gut Liver2016https://conductscience.org/library/papers/27784846PubMed
25463603NS5B induces up-regulation of the BH3-only protein, BIK, essential for the hepatitis C virus RNA replication and viral release.Virology2015https://conductscience.org/library/papers/25463603PubMed

See all 70 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/53329

GET https://conductscience.org/api/papers/v1/53329/cited_by?page=2